Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids.

Periodontitis has been traditionally regarded as a chronic inflammatory oral infection. However, recent studies indicate that this oral disease may have profound effects on systemic health. The search for cellular/molecular mechanisms linking periodontitis to changes in systemic health and systemic physiology has resulted in the evolution of a new area of lipid research establishing linkages between existing multidisciplinary biomedical literature, recent observations concerning the effects of serum lipids on immune cell phenotype/function, and a heightened interest in systemic responses to chronic localized infections. There appears to be more than a casual relationship between serum lipid levels and systemic health (particularly cardiovascular disease, diabetes, tissue repair capacity, and immune cell function), susceptibility to periodontitis, and serum levels of pro-inflammatory cytokines. In terms of the potential relationship between periodontitis and systemic disease, it is possible that periodontitis-induced changes in immune cell function cause metabolic dysregulation of lipid metabolism through mechanisms involving proinflammatory cytokines. Sustained elevations of serum lipids and/or pro-inflammatory cytokines may have a serious negative impact on systemic health. The purpose of this paper is to present the background, supporting data, and hypotheses related to this concept. As active participants in this emerging and exciting area of investigation, we hope to stimulate interest and awareness among biomedical scientists and practitioners.

[1]  C. Cutler,et al.  Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. , 1999, Journal of periodontology.

[2]  F. Numano,et al.  The Effect of Glucose and Advanced Glycosylation End Products on IL‐6 Production by Human Monocytes , 1994, Annals of the New York Academy of Sciences.

[3]  J. Slots,et al.  Casual or Causal Relationship between Periodontal Infection and Non-oral Disease? , 1998, Journal of dental research.

[4]  N. Savage,et al.  Characterization of serum antibodies to Porphyromonas gingivalis in individuals with and without periodontitis. , 1998, Oral microbiology and immunology.

[5]  J. Ainamo,et al.  Periodontal conditions in insulin-dependent diabetes mellitus. , 1992, Journal of clinical periodontology.

[6]  A. Iacopino,et al.  Diabetic periodontitis: possible lipid-induced defect in tissue repair through alteration of macrophage phenotype and function. , 2008, Oral diseases.

[7]  J. Mcghee,et al.  Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. , 1997, Journal of periodontal research.

[8]  S. Socransky,et al.  Levels of interleukin 1 beta in tissue from sites of active periodontal disease. , 1991, Journal of clinical periodontology.

[9]  R. Genco,et al.  A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells , 1997, Infection and immunity.

[10]  D. Williamson,et al.  Dental disease and risk of coronary heart disease and mortality. , 1993, BMJ.

[11]  F. Pociot,et al.  A Tumour Necrosis Factor Beta Gene Polymorphism in Relation to Monokine Secretion and Insulin‐Dependent Diabetes Mellitus , 1991, Scandinavian journal of immunology.

[12]  R. G. Deshpande,et al.  Invasion of Aortic and Heart Endothelial Cells byPorphyromonas gingivalis , 1998, Infection and Immunity.

[13]  R. Elkeles,et al.  Treatment of diabetes: the effect on serum lipids and lipoproteins. , 1991, Postgraduate medical journal.

[14]  C. Cutler,et al.  Functional differences in human neutrophils isolated pre‐ and post‐prandially , 1991, FEBS letters.

[15]  J. Nilsson,et al.  Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL , 1996 .

[16]  R. Genco,et al.  Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). , 1982, Journal of the American Dental Association.

[17]  Y. Kono,et al.  Cytokines and periodontal disease: immunopathological role of interleukins for B cell responses in chronic inflamed gingival tissues. , 1993, Journal of periodontology.

[18]  A. Tabares,et al.  Triglyceride kinetics, tissue lipoprotein lipase, and liver lipogenesis in septic rats. , 1990, The American journal of physiology.

[19]  G. Seymour,et al.  Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. , 1997, Periodontology 2000.

[20]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[21]  R. Jonsson,et al.  Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease. , 1994, Journal of clinical periodontology.

[22]  R. Jackson,et al.  Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. , 1994, Journal of lipid research.

[23]  S. Takashiba,et al.  Periodontal disease as a complication of diabetes mellitus. , 1998, Annals of periodontology.

[24]  G. Koch,et al.  Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. , 1994, Journal of periodontology.

[25]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[26]  T. Tervonen,et al.  Relation of diabetes control to periodontal pocketing and alveolar bone level. , 1986, Oral surgery, oral medicine, and oral pathology.

[27]  A. Dutta-Roy,et al.  Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effects of essential fatty acid metabolism. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.

[28]  A. Cambon-Thomsen,et al.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus , 1993 .

[29]  S. Offenbacher Periodontal diseases: pathogenesis. , 1996, Annals of periodontology.

[30]  J. Selby,et al.  Epidemiology and Prevention of Periodontal Disease in Individuals With Diabetes , 1991, Diabetes Care.

[31]  R. Tilvis,et al.  Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin-dependent diabetic women. , 1985, The Journal of clinical endocrinology and metabolism.

[32]  M. Boermeester,et al.  Effect of hypertriglyceridemia on endotoxin responsiveness in humans , 1995, Infection and immunity.

[33]  A. Garg Lipid-Lowering Therapy and Macrovascular Disease in Diabetes Mellitus , 1992, Diabetes.

[34]  R. Arnold,et al.  Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. , 1997, Journal of periodontology.

[35]  H. Imura,et al.  Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems , 1991, Clinical endocrinology.

[36]  A. Cerami,et al.  Detection of circulating tumor necrosis factor after endotoxin administration. , 1988, The New England journal of medicine.

[37]  Lopes-Virella Mf Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. , 1993 .

[38]  B. Michalowicz,et al.  Detection of local and systemic cytokines in adult periodontitis. , 1996, Journal of periodontology.

[39]  A. D. Smith,et al.  The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. , 1984, Biochimica et biophysica acta.

[40]  H. Kiyono,et al.  Inflammatory mediators of the terminal dentition in adult and early onset periodontitis , 1998 .

[41]  S. Offenbacher,et al.  Changes in crevicular fluid levels of interleukin‐1β, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor α in experimental gingivitis in humans , 1993 .

[42]  H. Löe Periodontal Disease: The sixth complication of diabetes mellitus , 1993, Diabetes Care.

[43]  H. Birkedal‐Hansen Role of cytokines and inflammatory mediators in tissue destruction. , 1993, Journal of periodontal research.

[44]  G. Lowe Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine. , 1998, Annals of periodontology.

[45]  G. Chisolm,et al.  Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation. , 1987, The Journal of biological chemistry.

[46]  T. Hagve,et al.  Effects of unsaturated fatty acids on cell membrane functions. , 1988, Scandinavian journal of clinical and laboratory investigation.

[47]  W. Loesche,et al.  Interactions between periodontal disease, medical diseases and immunity in the older individual. , 1998, Periodontology 2000.

[48]  W. Beisel,et al.  Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. , 1976, The Journal of infectious diseases.

[49]  P. Conneally,et al.  Periodontal disease in diabetics. , 1967, Journal of periodontology.

[50]  S. Socransky,et al.  The Bacterial Etiology of Destructive Periodontal Disease: Current Concepts. , 1992, Journal of periodontology.

[51]  T. Collins Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[52]  C. Cutler,et al.  Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model. , 1998, Journal of periodontology.

[53]  R. Page,et al.  The role of inflammatory mediators in the pathogenesis of periodontal disease. , 1991, Journal of periodontal research.

[54]  S. Amar,et al.  Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter , 1995, Infection and immunity.

[55]  S. Offenbacher,et al.  Diabetes as a modifier of periodontal disease expression. , 1994, Periodontology 2000.

[56]  R. Page The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. , 1998, Annals of periodontology.

[57]  C. Cutler,et al.  Association between periodontitis and hyperlipidemia: cause or effect? , 1999, Journal of periodontology.

[58]  T. Ervasti,et al.  Relation between control of diabetes and gingival bleeding. , 1985, Journal of periodontology.

[59]  M. Garg,et al.  Dietary fat: exogenous determination of membrane structure and cell function , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  R. Tompkins Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome. , 1994, Critical care medicine.

[61]  J. Ainamo,et al.  A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. , 1994, Journal of clinical periodontology.

[62]  J. Beck,et al.  Periodontal Infection as a Possible Risk Factor for Preterm Low Birth Weight. , 1996, Journal of periodontology.

[63]  J. Mølvig A model of the pathogenesis of insulin-dependent diabetes mellitus. , 1992, Danish medical bulletin.

[64]  N. Schneiderman,et al.  Insulin, health behaviors, and lipid metabolism. , 1993, Metabolism: clinical and experimental.

[65]  S. Clarke,et al.  Regulation of gene transcription by polyunsaturated fatty acids. , 1993, Progress in lipid research.

[66]  S. Socransky,et al.  Potential pathogenic mechanisms of periodontitis associated pregnancy complications. , 1998, Annals of periodontology.

[67]  B. Howard,et al.  Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.

[68]  K N Frayn,et al.  Sepsis and fat metabolism , 1996, The British journal of surgery.

[69]  A. Schmidt,et al.  Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. , 1993, The Journal of clinical investigation.

[70]  R. Genco,et al.  Periodontal disease and diabetes mellitus: a two-way relationship. , 1998, Annals of periodontology.

[71]  R. Genco Periodontal disease and risk for myocardial infarction and cardiovascular disease , 1998 .

[72]  K. Feingold,et al.  Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.

[73]  S. Fried,et al.  Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. , 1989, Journal of lipid research.

[74]  J. Gallin,et al.  Serum lipids in infection. , 1969, The New England journal of medicine.

[75]  O. Arisaka,et al.  Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. , 1991, Prostaglandins, leukotrienes, and essential fatty acids.

[76]  C. Cutler,et al.  Diabetes-induced impairment of macrophage cytokine release in a rat model: potential role of serum lipids. , 1998, Life sciences.

[77]  T. Poll,et al.  Tumour necrosis factor-α: Its role in the metabolic response to sepsis , 1993 .

[78]  Horrobin Df The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. , 1988 .

[79]  J. Hayashi,et al.  Effects of cytokines and periodontopathic bacteria on the leukocyte function-associated antigen 1/intercellular adhesion molecule 1 pathway in gingival fibroblasts in adult periodontitis , 1994, Infection and immunity.

[80]  F. Scannapieco Position paper of The American Academy of Periodontology: periodontal disease as a potential risk factor for systemic diseases. , 1998, Journal of periodontology.

[81]  I. Lamster,et al.  Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis. , 1998, Journal of clinical periodontology.

[82]  S. M. Sims,et al.  Osteoclast activation in inflammatory periodontal diseases. , 2008, Oral diseases.

[83]  C. Dinarello,et al.  The role of interleukin-1 in disease. , 1993, The New England journal of medicine.

[84]  S. Offenbacher,et al.  Diagnostic Potential of Host Response Mediators , 1993, Advances in dental research.

[85]  S. Nares,et al.  In vitro alteration of macrophage phenotype and function by serum lipids , 1999, Cell and Tissue Research.

[86]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[87]  A. Iacopino,et al.  Platelet-derived growth factor levels in wounds of diabetic rats. , 1995, Life sciences.

[88]  B. Howard Lipoprotein metabolism in diabetes. , 1994, Current opinion in lipidology.

[89]  T. van der Poll,et al.  Model for whole body production of tumour necrosis factor-alpha in experimental endotoxaemia in healthy subjects. , 1994, Clinical science.

[90]  A. Dasanayake Poor periodontal health of the pregnant woman as a risk factor for low birth weight. , 1998, Annals of periodontology.

[91]  R. Arnold,et al.  Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. , 1997, Journal of clinical periodontology.

[92]  S. Socransky,et al.  Serum antibodies reacting with subgingival species in refractory periodontitis subjects. , 1998, Journal of clinical periodontology.

[93]  K. Hove,et al.  Diabetes and the periodontal patient. , 1970, Journal of periodontology.

[94]  C. Alvarez,et al.  Lipids, lipoproteins, and apoproteins in serum during infection. , 1986, Clinical chemistry.

[95]  K. Feingold,et al.  Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.

[96]  A. Gwosdow,et al.  Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis. , 1990, The American journal of physiology.

[97]  J. Beck,et al.  PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. , 1998, Annals of periodontology.

[98]  P. Eke,et al.  Defective neutrophil function in an insulin-dependent diabetes mellitus patients. A case report. , 1991, Journal of periodontology.

[99]  A. Schmidt,et al.  Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[100]  M. Barnett,et al.  Absence of periodontitis in a population of insulin-dependent diabetes mellitus (IDDM) patients. , 1984, Journal of periodontology.

[101]  P. Fives-Taylor,et al.  Models of invasion of enteric and periodontal pathogens into epithelial cells: a comparative analysis. , 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[102]  R. Genco,et al.  Periodontal disease in non-insulin-dependent diabetes mellitus. , 1991, Journal of periodontology.

[103]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[104]  M. Nieminen,et al.  Association between dental health and acute myocardial infarction. , 1989, BMJ.

[105]  M. Meyer,et al.  Dental plaque, platelets, and cardiovascular diseases. , 1998, Annals of periodontology.

[106]  M. Jensen,et al.  Stimulation of Lipolysis in Humans by Physiological Hypercortisolemia , 1991, Diabetes.

[107]  T. Sayers,et al.  Relationship of TNF to interleukins. , 1992, Immunology series.

[108]  M. Kaste,et al.  Dental infections in association with cerebral infarction in young and middle‐aged men , 1989, Journal of internal medicine.